DrugPatentWatch Database Preview
Details for Biologics License Application: 103665
» See Plans and Pricing
Summary for BLA: 103665
| Tradename: | NOVOSEVEN |
| Applicant: | Novo Nordisk |
| Ingredient: | coagulation factor viia (recombinant) |
| Patents: | 1 |
| Approval Date: | Oct 29, 2012 |
| Suppliers: see list | 1 |
US Patents for BLA: 103665
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk | NOVOSEVEN | coagulation factor viia (recombinant) | KIT | 103665 | 1 | 2012-10-29 | Start Trial | Corning Incorporated (Corning, NY) | 2033-04-24 | search | ||
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
